Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000474560 | SCV000544846 | likely pathogenic | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2018-05-07 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Likely Pathogenic. Several different truncating variants downstream from this event (c.8556delC, p.Tyr2853Thrfs*10; c.8571dupA, p.Leu2858Thrfs*3; c.8599C>T, p.Gln2867*) have been observed in unrelated individuals with Marfan syndrome (PMID: 25101912, 26410935, 19293843). This suggests that the residues downstream are critical for FBN1 protein function and that other truncating variants that do not result in nonsense mediated decay may also be pathogenic. This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a FBN1-related disease. ClinVar contains an entry for this variant (Variation ID: 406284). This sequence change deletes 1 nucleotide from exon 66 of the FBN1 mRNA (c.8561delT), causing a frameshift at codon 2854. This creates a premature translational stop signal in the last exon of the FBN1 mRNA (p.Leu2854Profs*9). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 17 amino acids of the FBN1 protein. |